Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity. (2018)

First Author: Bodewes ILA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kex490

PubMed Identifier: 29474655

Publication URI: http://europepmc.org/abstract/MED/29474655

Type: Journal Article/Review

Volume: 57

Parent Publication: Rheumatology (Oxford, England)

Issue: 5

ISSN: 1462-0324